Bausch Health Cos Share Holder Equity 2010-2023 | BHC
Bausch Health Cos share holder equity from 2010 to 2023. Share holder equity can be defined as the sum of preferred and common equity items
Bausch Health Cos Annual Share Holder Equity
(Millions of US $) |
| 2023 |
$-82 |
| 2022 |
$260 |
| 2021 |
$-34 |
| 2020 |
$605 |
| 2019 |
$1,136 |
| 2018 |
$2,815 |
| 2017 |
$5,944 |
| 2016 |
$3,258 |
| 2015 |
$6,029 |
| 2014 |
$5,402 |
| 2013 |
$5,233 |
| 2012 |
$3,717 |
| 2011 |
$3,930 |
| 2010 |
$4,911 |
| 2009 |
$1,354 |
Bausch Health Cos Quarterly Share Holder Equity
(Millions of US $) |
| 2023-12-31 |
$-82 |
| 2023-09-30 |
$-235 |
| 2023-06-30 |
$271 |
| 2023-03-31 |
$145 |
| 2022-12-31 |
$260 |
| 2022-09-30 |
$433 |
| 2022-06-30 |
$253 |
| 2022-03-31 |
$-141 |
| 2021-12-31 |
$-34 |
| 2021-09-30 |
$-135 |
| 2021-06-30 |
$-611 |
| 2021-03-31 |
$-124 |
| 2020-12-31 |
$605 |
| 2020-09-30 |
$655 |
| 2020-06-30 |
$546 |
| 2020-03-31 |
$790 |
| 2019-12-31 |
$1,136 |
| 2019-09-30 |
$2,560 |
| 2019-06-30 |
$2,688 |
| 2019-03-31 |
$2,779 |
| 2018-12-31 |
$2,815 |
| 2018-09-30 |
$3,237 |
| 2018-06-30 |
$3,558 |
| 2018-03-31 |
$4,523 |
| 2017-12-31 |
$5,944 |
| 2017-09-30 |
$5,422 |
| 2017-06-30 |
$4,029 |
| 2017-03-31 |
$3,994 |
| 2016-12-31 |
$3,258 |
| 2016-09-30 |
$4,274 |
| 2016-06-30 |
$5,403 |
| 2016-03-31 |
$5,776 |
| 2015-12-31 |
$6,029 |
| 2015-09-30 |
$6,465 |
| 2015-06-30 |
$6,558 |
| 2015-03-31 |
$6,575 |
| 2014-12-31 |
$5,402 |
| 2014-09-30 |
$5,234 |
| 2014-06-30 |
$5,367 |
| 2014-03-31 |
$5,204 |
| 2013-12-31 |
$5,233 |
| 2013-09-30 |
$5,061 |
| 2013-06-30 |
$5,703 |
| 2013-03-31 |
$3,587 |
| 2012-12-31 |
$3,717 |
| 2012-09-30 |
$3,785 |
| 2012-06-30 |
$3,695 |
| 2012-03-31 |
$4,076 |
| 2011-12-31 |
$3,930 |
| 2011-09-30 |
$4,014 |
| 2011-06-30 |
$4,665 |
| 2011-03-31 |
$4,709 |
| 2010-12-31 |
$4,911 |
| 2010-09-30 |
$5,350 |
| 2010-06-30 |
$1,361 |
| 2010-03-31 |
$1,344 |
| 2009-12-31 |
$1,354 |
| 2009-09-30 |
$1,291 |
| 2009-06-30 |
$1,254 |
| 2009-03-31 |
$1,177 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$3.183B |
$8.757B |
|
Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of eye-health, gastroenterology (GI), and dermatology.
|
